1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross - a podcast by Vinay Prasad, MD MPH

We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center.

Further episodes of Plenary Session

Further podcasts by Vinay Prasad, MD MPH

Website of Vinay Prasad, MD MPH